Medite Cancer Diagnostics, Inc.
Medical device company · Chicago, Illinois, United States
Medite Cancer Diagnostics, Inc. is a medical device company headquartered in Chicago, Illinois, United States. It has reported private securities offerings to the US SEC, most recently $870,000 sold in a notice filed in 2018.
Medite Cancer Diagnostics at a glance
What does Medite Cancer Diagnostics do?
Private fundraising reported to the SEC
11 Form D notices; the most recent reported $870,000 sold (2018).
Frequently asked questions about Medite Cancer Diagnostics
Where is Medite Cancer Diagnostics headquartered?
Medite Cancer Diagnostics, Inc. is headquartered in Chicago, Illinois, United States.
What does Medite Cancer Diagnostics do?
Medite Cancer Diagnostics, Inc. is a medical device company. Its SEC industry classification is Surgical & Medical Instruments & Apparatus.
Similar companies
- Coapt LLCChicago, Illinois, United States
- Surgical Innovation Associates Inc.Chicago, Illinois, United States
- GE HealthCare Technologies Inc.Chicago, Illinois, United States
- SimBioSys, Inc.Chicago, Illinois, United States
- Novian Health Inc.Chicago, Illinois, United States
- Cast21, Inc.Chicago, Illinois, United States
- ImmersiveTouch, Inc.Chicago, Illinois, United States
- Adaptive Health, Inc.Chicago, Illinois, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences